Nazione: Stati Uniti
Lingua: inglese
Fonte: NLM (National Library of Medicine)
AZELAIC ACID (UNII: F2VW3D43YT) (AZELAIC ACID - UNII:F2VW3D43YT)
A-S Medication Solutions
TOPICAL
PRESCRIPTION DRUG
FINACEA Gel, 15% is indicated for topical treatment of the inflammatory papules and pustules of mild to moderate rosacea. Limitations of Use Although some reduction of erythema which was present in patients with papules and pustules of rosacea occurred in clinical studies, efficacy for treatment of erythema in rosacea in the absence of papules and pustules has not been evaluated. None. Risk Summary Azelaic acid is minimally absorbed systemically following topical route of administration, and maternal use is not expected to result in fetal exposure to the drug [see Clinical Pharmacology (12.3)]. In animal reproduction studies, embryofetal toxicity was noted when azelaic acid was administered orally during the period of organogenesis at doses 162, 19, and 65 times the maximum recommended human dose (MRHD) in rats, rabbits, and monkeys, respectively. Maternal toxicity was noted at these doses but no malformations were observed in these embryofetal developmental studies (see Data). The background risk of major b
Product: 50090-4473 NDC: 50090-4473-0 50 g in a TUBE / 1 in a CARTON
New Drug Application
FINACEA- AZELAIC ACID GEL A-S MEDICATION SOLUTIONS ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE FINACEA GEL SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR FINACEA GEL. FINACEA (AZELAIC ACID) GEL, FOR TOPICAL USE INITIAL U.S. APPROVAL: 1995 INDICATIONS AND USAGE FINACEA (azelaic acid) Gel, 15% is indicated for topical treatment of the inflammatory papules and pustules of mild to moderate rosacea (1). Limitations of Use Efficacy for treatment of erythema in rosacea in the absence of papules and pustules has not been evaluated. (1) DOSAGE AND ADMINISTRATION Apply a thin layer twice daily to affected area(s). (2) Use only very mild soaps or soapless cleansing lotion and pat dry with a soft towel before applying FINACEA Gel. (2) Wash hands immediately following application. (2) Cosmetics may be applied after the application of FINACEA Gel has dried. (2) Avoid use of alcoholic cleansers, tinctures and astringents, abrasives and peeling agents. (2) For topical use. (2) Not for oral, ophthalmic or intravaginal use. (2) DOSAGE FORMS AND STRENGTHS Gel, 15% (3) CONTRAINDICATIONS None. (4) WARNINGS AND PRECAUTIONS _Hypersensitivity_: Hypersensitivity reactions, including cases of angioedema, eye swelling, facial swelling, dyspnea, urticaria, and adverse skin reactions, have been reported. In case of known hypersensitivity to any component of the gel, avoid the use of FINACEA Gel. If hypersensitivity develops, discontinue treatment and institute appropriate therapy. (5.1) _Skin Reactions:_ Skin irritation (i.e. pruritus, burning or stinging) may occur, usually during the first few weeks of treatment. If sensitivity or severe irritation develops and persists, discontinue treatment and institute appropriate therapy. (5.2) _Hypopigmentation:_ Isolated cases of hypopigmentation occurred after azelaic acid use. Monitor patients with dark complexion for early signs of hypopigmentation (5.2) _Eye and Mucous Membrane Irritation:_ FINACEA Gel has been Leggi il documento completo